Cassiopea Announces Results for First Half of 2020
Cassiopea S.p.A., a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, today announced its half-year 2020 results for the period ended 30 June 2020.